Saturday, May 8, 2021
HomeStatementsIran: COVID-19 Fatalities in 541 Cities Surpass 274,500

Iran: COVID-19 Fatalities in 541 Cities Surpass 274,500

NCRI logoThe National Coronavirus Combat Taskforce (NCCT): At the peak of the third COVID-19 outbreak, we had 23,000 patients hospitalized in one day, while in this peak, we reached 50,000

  • Alireza Reisi, the spokesperson for NCCT: We have 250,000 to 300,000 outpatients daily. The height of the fourth COVID-19 outbreak peak is twice the height of the third peak. Several cases of the South African variant are identified in the south of the country. We also had a few patients suspected of contracting the Indian COVID-19 variant waiting for test results. (ISNA news agency, Mary 2, 2021)
  • Tehran City Council: Afghan citizens are not allowed to be vaccinated due to the lack of a national identification code. If vaccines cannot be given to (Afghan) municipal workers, how can these citizens be employed? (Mehr news agency, May 2, 2021)
  • Isfahan University of Medical Sciences: Except for the Kashan region, 2,299 COVID-19 patients are still hospitalized, 374 in ICU. In the past 24 hours, 27 people have lost their lives. (Mehr, May 2, 2021)
  • Mazandaran and Babol Universities of Medical Sciences: Currently, 1,152 COVID-19 patients are hospitalized, of which 270 are admitted to ICU wards. (ISNA, May 2, 2021)

The People’s Mojahedin Organization of Iran (PMOI/MEK) announced on Sunday, May 2, 2021, that the COVID-19 death toll in 541 cities had exceeded 274,500. The number of victims in Tehran has reached  63,121, Isfahan 18,000, Razavi Khorasan 17,105, Khuzestan 16,764, Mazandaran 11,420, Lorestan 11,408, East Azerbaijan 11,238, Gilan 9,541, Qom 9,260, Fars 8,502, Alborz 7,233, Golestan 6,885, Sistan and Baluchestan 6,286, Hamedan 6,203, Kerman 6,184, Central Province 5,743, Kermanshah 5,504, Yazd  4,772, North Khorasan 4,078, Zanjan 3,025, Ilam 2,826, South Khorasan 2,701, and Kohgiluyeh and Boyer-Ahmad 2,144.

Secretariat of the National Council of Resistance of Iran (NCRI)

May 2, 2021